TUBB7P

Across TCGA pan-cancer cohorts, TUBB7P Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TUBB7P data layer compared with 19 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher TUBB7P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TUBB7P expression acts as an unfavorable survival marker.

BRCA, LUSC, and LGG are the cancer types where TUBB7P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.100	0.578	<.001	24	view →
LUSC	DFS	Median	III,IV	0.152	0.781	.004	12	view →
LGG	OS	Median	All	0.300	0.830	.004	6	view →
SARC	OS	Median	All	0.133	0.860	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TUBB7P–BRCA (OS)

Open the BRCA breakdown →